Intravitreal injections using a novel conjunctival mould: A comparison with a conventional technique

British Journal of Ophthalmology

Volumn 97, Issue 4, 2013, Pages 395-397

  Ratnarajan, Gokulan ^a   Nath, Remin ^a   Appaswamy, Shivashankar ^a   Watson, Sarah Lucie ^a  

^a ROYAL BERKSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB;

ARTICLE; CONJUNCTIVAL HEMORRHAGE; CONJUNCTIVAL MOLD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG DELIVERY DEVICE; HUMAN; INTRAVITREAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PAIN; PATIENT PREFERENCE; PATIENT SAFETY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOPHAKIA; REPRODUCIBILITY; RETINA MACULA AGE RELATED DEGENERATION; SUBCONJUNCTIVAL HEMORRHAGE; SURGEON; VISUAL ANALOG SCALE;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; COSTS AND COST ANALYSIS; DRUG DELIVERY SYSTEMS; EQUIPMENT DESIGN; EYE PAIN; HUMANS; INTRAVITREAL INJECTIONS; MACULAR DEGENERATION; PAIN MEASUREMENT; PATIENT PREFERENCE; PHYSICIANS; PROSPECTIVE STUDIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84875229144     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2012-302155     Document Type: Article

References (11)

1. Rosenfeld PJ, Brown DM, Heier JS, et al., for the MARINA Study Group. Ranibizumab for neovascular aged-related macular degeneration. N Engl J Med 2006;355:1419-31. (Pubitemid 44511557)
2. Brown DM, Kaiser PK, Michels M, et al., for the ANCHOR Study Group. Ranibizumab verses Verteporfin for neovascular aged-related macular degeneration. N Engl J Med 2006;355:1432-44. (Pubitemid 44511558)
3. Brown DM, Campochiaro PA, Singh RP, et al., for the CRUISE Investigators. Ranibizumab for macular edema following central retinal vein occlusion: 6-month primary endpoint results of a phase III study. Ophthalmology 2010;117:1124-33.
4. Campochiaro PA, Heier JS, Feiner L, et al., for the BRAVO Investigators. Ranibizumab for macular edema following branch retinal vein occlusion: 6-month primary endpoint results of a phase III study. Ophthalmology 2010;117:1102-12.
5. Scott IU, Ip MS, VanVeldhuisen PC, et al. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. Arch Ophthalmol 2009;127:1115-28.
6. Rodriquez-Fontal M, Alfaro V, Kerrison JB, et al. Ranibizumab for diabetic retinopathy. Curr Diabetes Rev 2009;5:47-51.
7. Jager RD, Aiello LP, Patel SC, et al. Risks of intravitreous injection: a comprehensive review. Retina 2004;24:676-98. (Pubitemid 39391758)
8. Ta CN. Minimizing the risk of endophthalmitis following intravitreous injections. Retina 2004;24:699-705. (Pubitemid 39391759)
9. Cintra LP, Lucena LR, Da Silva JA, et al. Comparative study of analgesic effectiveness using three different anaesthetic techniques for intravitreal injections of bevacizumab. Ophthalmic Surg Lasers Imaging 2009;40:13-18.
10. Blaha GR, Tilton EP, Barouch FC, et al. Randomized trial of anesthetic methods for intravitreal injections. Retina 2011;31:535-9.
11. Royal College of Ophthalmologists Clinical Guidelines. http://www.rcophth.ac.uk/page.asp?section=451§ionTitle= Clinical+Guidelines (accessed 14 Sep 2012).